The Cost of Clinical Trials Is Set To Increase

Commercialising a medicine is a far from straightforward task for research-based pharmaceutical companies. The process of identifying a candidate compound, analysing its potential and progressing through clinical trials to show valuable efficacy can take as long as 10 years and cost as much as US$1bn. According to The Pharmaceutical Research and Manufacturers of America (PhRMA), US$626mn (on average) is invested in clinical testing for biologic drugs, whereas testing small molecule/chemical-based drugs requires approximately

To read the full article, please choose one of the following options: